Richard E. Uihlein - Sep 17, 2021 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director, 10%+ Owner
Signature
/s/ Jack W. Callicutt, by power of attorney
Stock symbol
GALT
Transactions as of
Sep 17, 2021
Transactions value $
$11,574,070,000,000
Form type
4
Date filed
9/21/2021, 04:30 PM
Next filing
Jan 25, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GALT Convertible Note Award $11.6T +1.16M +13.09% $10,000,000.00* 10M Sep 17, 2021 Common Stock 1.16M $8.64 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Excludes interest that may accrue following issuance of the Note.
F2 The Note is convertible upon 60 days prior written notice by the noteholder.
F3 In consideration for the Convertible Note, the Reporting Person loaned ten million dollars to the Company.
F4 Represents the principal amount of the note payable.